X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Merck Ltd with ACTAVIS INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs ACTAVIS (US) - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 MERCK LTD   ACTAVIS
EQUITY SHARE DATA
    MERCK LTD
Dec-16
ACTAVIS
Dec-14
MERCK LTD/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,06017,481-   
Low Rs62310,663-   
Sales per share (Unadj.) Rs632.43,147.8-  
Earnings per share (Unadj.) Rs45.7-392.8-  
Cash flow per share (Unadj.) Rs62.3288.8-  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.86,827.6-  
Shares outstanding (eoy) m16.60265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.34.5 29.8%   
Avg P/E ratio x18.4-35.8 -51.4%  
P/CF ratio (eoy) x13.548.7 27.7%  
Price / Book Value ratio x2.22.1 105.0%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,9693,741,736 0.4%   
No. of employees `0001.621.6 7.3%   
Total wages/salary Rs m1,4870-   
Avg. sales/employee Rs Th6,631.938,750.6 17.1%   
Avg. wages/employee Rs Th939.20-   
Avg. net profit/employee Rs Th479.4-4,835.7 -9.9%   
INCOME DATA
Net Sales Rs m10,498837,013 1.3%  
Other income Rs m242-2,089 -11.6%   
Total revenues Rs m10,741834,924 1.3%   
Gross profit Rs m1,135107,526 1.1%  
Depreciation Rs m276181,244 0.2%   
Interest Rs m026,401 0.0%   
Profit before tax Rs m1,102-102,208 -1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-7,497 0.0%   
Tax Rs m343-5,255 -6.5%   
Profit after tax Rs m759-104,450 -0.7%  
Gross profit margin %10.812.8 84.2%  
Effective tax rate %31.15.1 605.8%   
Net profit margin %7.2-12.5 -57.9%  
BALANCE SHEET DATA
Current assets Rs m6,410440,999 1.5%   
Current liabilities Rs m8,828321,618 2.7%   
Net working cap to sales %-23.014.3 -161.5%  
Current ratio x0.71.4 52.9%  
Inventory Days Days5858 99.4%  
Debtors Days Days3866 57.9%  
Net fixed assets Rs m1,406102,208 1.4%   
Share capital Rs m1660-   
"Free" reserves Rs m6,2860-   
Net worth Rs m6,4551,815,450 0.4%   
Long term debt Rs m0951,332 0.0%   
Total assets Rs m8,8283,327,123 0.3%  
Interest coverage xNM-2.9-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.3 472.7%   
Return on assets %8.6-2.3 -366.4%  
Return on equity %11.8-5.8 -204.4%  
Return on capital %17.1-3.0 -567.2%  
Exports to sales %8.30-   
Imports to sales %21.00-   
Net fx Rs m-1,6530-   
CASH FLOW
From Operations Rs m1,070143,731 0.7%  
From Investments Rs m-750-344,148 0.2%  
From Financial Activity Rs m-150193,361 -0.1%  
Net Cashflow Rs m171-7,055 -2.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 64.08 Rs / USD

Compare MERCK LTD With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare MERCK LTD With: STERLING BIOTECH  NOVARTIS  SANOFI INDIA  STRIDES SHASUN LTD  UNICHEM LAB  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 22, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS